Alpha Registry
Claim a profile

Governance brief

Company Governance Record

Canonical ID
alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551
Published claims
13
Mandate and committee claims
10
Evidence sources
3
Last reviewed
Sep 2, 2026
Verification
Source reported

Counts describe published records, not completeness. Missing fields remain unknown, not zero.

Record coverage summary

  • identityPublished
  • businessPublished
  • leadershipPublished
  • board and committeesPublished
  • governanceNot asserted
  • financialsNot asserted
  • workforceNot asserted
  • ownershipNot asserted
  • EvalsNot published
  • market and index contextPublished

Public retrieval: Allowed · Agent retrieval: Allowed · Redistribution: Not granted

Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-02T15:37:51.610363+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/cns-pharmaceuticals-inc.md
Open Markdown

CNS Pharmaceuticals, Inc.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:14cbf1a0-53bc-4e86-9d90-3af489846551
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/cns-pharmaceuticals-inc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims13
Claims under review1
Evidence records3
Conflicts0
Conflicts in internal review0
Observed2026-09-02T15:37:51.610363+00:00
Last reviewed2026-09-02T15:37:51.610363+00:00

Identity

  • Legal name: CNS Pharmaceuticals, Inc.
  • Display name: CNS Pharmaceuticals, Inc.

Leadership

  • Amy Mahery: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • Bettina M. Cockroft: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • Faith L. Charles: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • Jeffry R. Keyes: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • Jerzy (George) Gumulka: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • John M. Climaco: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:2.
  • Christopher S. Downs: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:3.
  • Donald Picker: Chief Science Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:3.
  • John M. Climaco: Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:3.
  • Sandra L. Silberman: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:3.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • CNS Pharmaceuticals, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:14cbf1a0-53bc-4e86-9d90-3af489846551:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations